Collaboration to Offer Customized NGS Technologies for Tumor Cell Analysis
Starting from minute and low-cellularity FFPE specimens, two new products now give access to samples that were previously inaccessible for genetic analysis.
Read MorePosted by Elaine Sanchez Wilson | Nov 22, 2016 | Molecular Diagnostics |
Starting from minute and low-cellularity FFPE specimens, two new products now give access to samples that were previously inaccessible for genetic analysis.
Read MorePosted by Elaine Sanchez Wilson | Nov 20, 2016 | Embedding Systems, Molecular Diagnostics |
Modifications to a next-generation sequencing pipeline can improve the utility of archived specimens.
Read MorePosted by Elaine Sanchez Wilson | Nov 14, 2016 | Molecular Diagnostics |
Together, the organizations plan to employ new, innovative ways to improve Mayo Clinic’s reporting workflows for researching inherited disease, enabling Illumina to develop an informatics platform and knowledge base that can improve and automate genomic interpretation.
Read MorePosted by Elaine Sanchez Wilson | Nov 8, 2016 | Molecular Diagnostics |
There is a growing body of evidence that molecular diagnostics could help point-of-care providers meet patients’ expectations regarding the speed and accuracy of their diagnoses.
Read MorePosted by Elaine Sanchez Wilson | Nov 8, 2016 | Molecular Diagnostics, Research |
The company is leading the UK’s Deciphering Developmental Disorders study, which has analyzed the exomes of around 14,000 children with severe, undiagnosed developmental disorders, as well as the exomes of their parents.
Read More